Literature DB >> 19089808

Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS).

Darya Gaysina1, Sarah Cohen-Woods, Philip C Chow, Livia Martucci, Alexandra Schosser, Harriet A Ball, Federica Tozzi, Julia Perry, Pierandrea Muglia, Ian W Craig, Peter McGuffin, Anne Farmer.   

Abstract

Recent studies suggest a degree of overlap in genetic susceptibility across the traditional categories of schizophrenia and bipolar disorder. There is some evidence for an association of the dystrobrevin binding protein 1 gene (DTNBP1) with schizophrenia, and, thus, this gene has also become a focus of further investigation in bipolar disorder (BD). The aim of our study is to explore the association of DTNBP1 with BD and with a sub phenotype, presence/absence of psychotic symptoms, in a sample of 515 patients with BD (ICD10/DSMIV) and 1,316 ethnically matched control subjects recruited from the UK. Seven DTNBP1 SNPs: rs2743852 (SNP C), rs760761 (P1320), rs1011313 (P1325), rs3213207 (P1635), rs2619539 (P1655), rs16876571 and rs17470454 were investigated using the SNPlex genotyping system and 1 SNP (rs2619522) genotypes were imputed. Association analyses were conducted in a sample of 452 cases and 956 controls. We found significant differences in genotypic and allelic frequencies of rs3213207 and rs760761 of DTNBP1 between bipolar patients and controls. We also showed a global haplotypic association and an association of a particular haplotype with BD. Our results are consistent with previous studies in term of a general association between DTNBP1 and bipolar disorder and provide additional evidence that a portion of the genotypic overlap between schizophrenia and bipolar affective disorder is attributable to this gene. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19089808     DOI: 10.1002/ajmg.b.30906

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  13 in total

1.  Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder.

Authors:  Dana Anderson; Babak A Ardekani; Katherine E Burdick; Delbert G Robinson; Majnu John; Anil K Malhotra; Philip R Szeszko
Journal:  Bipolar Disord       Date:  2013-06-25       Impact factor: 6.744

Review 2.  Genomics and pharmacogenomics of schizophrenia.

Authors:  Ramón Cacabelos; Rocío Martínez-Bouza
Journal:  CNS Neurosci Ther       Date:  2010-08-16       Impact factor: 5.243

3.  Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia.

Authors:  Glenn T Konopaske; Darrick T Balu; Kendall T Presti; Grace Chan; Francine M Benes; Joseph T Coyle
Journal:  Schizophr Res       Date:  2018-05-11       Impact factor: 4.939

4.  High-resolution chromosome ideogram representation of recognized genes for bipolar disorder.

Authors:  Lindsay N Douglas; Austen B McGuire; Ann M Manzardo; Merlin G Butler
Journal:  Gene       Date:  2016-04-07       Impact factor: 3.688

Review 5.  Clinical and molecular genetics of psychotic depression.

Authors:  Katharina Domschke
Journal:  Schizophr Bull       Date:  2013-03-19       Impact factor: 9.306

6.  Stressful life events and the serotonin transporter gene (5-HTT) in recurrent clinical depression.

Authors:  Helen L Fisher; Sarah Cohen-Woods; Georgina M Hosang; Rudolf Uher; Georgia Powell-Smith; Robert Keers; Maria Tropeano; Ania Korszun; Lisa Jones; Ian Jones; Mike Owen; Nick Craddock; Ian W Craig; Anne E Farmer; Peter McGuffin
Journal:  J Affect Disord       Date:  2011-10-06       Impact factor: 4.839

7.  Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study.

Authors:  Aleksey Shatunov; Kin Mok; Stephen Newhouse; Michael E Weale; Bradley Smith; Caroline Vance; Lauren Johnson; Jan H Veldink; Michael A van Es; Leonard H van den Berg; Wim Robberecht; Philip Van Damme; Orla Hardiman; Anne E Farmer; Cathryn M Lewis; Amy W Butler; Olubunmi Abel; Peter M Andersen; Isabella Fogh; Vincenzo Silani; Adriano Chiò; Bryan J Traynor; Judith Melki; Vincent Meininger; John E Landers; Peter McGuffin; Jonathan D Glass; Hardev Pall; P Nigel Leigh; John Hardy; Robert H Brown; John F Powell; Richard W Orrell; Karen E Morrison; Pamela J Shaw; Christopher E Shaw; Ammar Al-Chalabi
Journal:  Lancet Neurol       Date:  2010-10       Impact factor: 44.182

Review 8.  Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.

Authors:  Alexandre A Guerin; Eric J Nestler; Michael Berk; Andrew J Lawrence; Susan L Rossell; Jee Hyun Kim
Journal:  Neurosci Biobehav Rev       Date:  2020-11-17       Impact factor: 8.989

9.  The DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans.

Authors:  S Trost; B Platz; J Usher; H Scherk; T Wobrock; S Ekawardhani; J Meyer; W Reith; P Falkai; O Gruber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-13       Impact factor: 5.270

10.  Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study.

Authors:  Niamh Mullins; Nader Perroud; Rudolf Uher; Amy W Butler; Sarah Cohen-Woods; Margarita Rivera; Karim Malki; Jack Euesden; Robert A Power; Katherine E Tansey; Lisa Jones; Ian Jones; Nick Craddock; Michael J Owen; Ania Korszun; Michael Gill; Ole Mors; Martin Preisig; Wolfgang Maier; Marcella Rietschel; John P Rice; Bertram Müller-Myhsok; Elisabeth B Binder; Susanne Lucae; Marcus Ising; Ian W Craig; Anne E Farmer; Peter McGuffin; Gerome Breen; Cathryn M Lewis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-06-25       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.